Skip to main content

Animations

MJFF Publications

3801 - 3810 of 8823 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2021
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.tjpad.2025.100133
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Mechanisms of Alpha-Synuclein-Seeded Aggregation in Neurons Revealed by Fluorescence Lifetime Imaging
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.5c00236
    Citation Count: 1
  • Summary Details
    OPEN
    Title: An atlas of protein phosphorylation dynamics during interferon signaling
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2412990122
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Genome-wide association study of neuropathological features in Lewy body disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaf105
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementia
    Journal Name: Psychiatry and Clinical Neurosciences
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/pcn.13810
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Parkinson’s Disease Mild Cognitive Impairment with MRI evidence of Cholinergic Nucleus 4 Degeneration: A New Subtype? (S32.005)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000212426
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Large‐scale deep multi‐layer analysis of Alzheimer’s disease brain reveals strong proteomic disease‐related changes not observed at the RNA level
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/alz.055041
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Design considerations for C9orf72 disease prevention trials
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf290
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adq2519
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Transcriptomic responses of lung mesenchymal cells during pneumonia
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.177084
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.